These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22377140)

  • 1. Factors associated with the non-completion of conventional anti-tuberculosis treatment in Peru.
    Culqui DR; Munayco E CV; Grijalva CG; Cayla JA; Horna-Campos O; Alva Ch K; Suarez O LA
    Arch Bronconeumol; 2012 May; 48(5):150-5. PubMed ID: 22377140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence of and factors for non-compliance to antituberculous treatment].
    Cáceres Fde M; Orozco LC
    Biomedica; 2007 Dec; 27(4):498-504. PubMed ID: 18320117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predicting non-completion of tuberculosis treatment among HIV-infected patients in Barcelona (1987-1996).
    Tangüis HG; Caylà JA; García de Olalla PG; Jansà JM; Brugal MT
    Int J Tuberc Lung Dis; 2000 Jan; 4(1):55-60. PubMed ID: 10654645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directly observed treatment is associated with reduced default among foreign tuberculosis patients in Thailand.
    Kapella BK; Anuwatnonthakate A; Komsakorn S; Moolphate S; Charusuntonsri P; Limsomboon P; Wattanaamornkiat W; Nateniyom S; Varma JK
    Int J Tuberc Lung Dis; 2009 Feb; 13(2):232-7. PubMed ID: 19146753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City.
    Li J; Munsiff SS; Tarantino T; Dorsinville M
    Int J Infect Dis; 2010 Apr; 14(4):e292-7. PubMed ID: 19656705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment.
    Trajman A; Long R; Zylberberg D; Dion MJ; Al-Otaibi B; Menzies D
    Int J Tuberc Lung Dis; 2010 May; 14(5):551-9. PubMed ID: 20392347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
    Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
    Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence is associated with the quality of professional-patient interaction in Directly Observed Treatment Short-course, DOTS.
    Mishra P; Hansen EH; Sabroe S; Kafle KK
    Patient Educ Couns; 2006 Oct; 63(1-2):29-37. PubMed ID: 16242297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of treatment completion and fatality among tuberculosis patients in Spain.
    Caylà JA; Caminero JA; Rey R; Lara N; Vallés X; Galdós-Tangüis H;
    Int J Tuberc Lung Dis; 2004 Apr; 8(4):458-64. PubMed ID: 15141739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.
    Chavez Pachas AM; Blank R; Smith Fawzi MC; Bayona J; Becerra MC; Mitnick CD
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):52-8. PubMed ID: 14974746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research and control of relapse tuberculosis cases].
    Yamagishi F; Toyota M
    Kekkaku; 2009 Dec; 84(12):767-8. PubMed ID: 20077861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing completion of treatment among tuberculosis patients in Mbarara District, Uganda.
    Nuwaha F
    East Afr Med J; 1997 Nov; 74(11):690-3. PubMed ID: 9557437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of pulmonary tuberculosis treatment in the tertiary care setting--Toronto 1992/93. Tuberculosis Treatment Completion Study Group.
    Wobeser W; Yuan L; Naus M
    CMAJ; 1999 Mar; 160(6):789-94. PubMed ID: 10189422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment completion in latent tuberculosis infection at specialist tuberculosis units in Spain.
    Anibarro L; Casas S; Paz-Esquete J; Gonzalez L; Pena A; Guerra MR; Sande D; Calviño L; Santin M;
    Int J Tuberc Lung Dis; 2010 Jun; 14(6):701-7. PubMed ID: 20487607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment interruptions and duration associated with default among new patients with tuberculosis in six regions of Russia.
    Jakubowiak W; Bogorodskaya E; Borisov S; Danilova I; Kourbatova E
    Int J Infect Dis; 2009 May; 13(3):362-8. PubMed ID: 19008141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic, health services and socio-economic factors associated with pulmonary tuberculosis mortality in Los Altos Region of Chiapas, Mexico.
    Nájera-Ortiz JC; Sánchez-Pérez HJ; Ochoa-Díaz H; Arana-Cedeño M; Lezama MS; Mateo MM
    Int J Epidemiol; 2008 Aug; 37(4):786-95. PubMed ID: 18511492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors associated with non-compliance with antidepressant treatment in Santiago, Chile].
    Jirón M; Escobar L; Arriagada L; Orellana S; Castro A
    Value Health; 2011; 14(5 Suppl 1):S115-8. PubMed ID: 21839881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with deaths among pulmonary tuberculosis patients: a case-control study with secondary data.
    Duarte EC; Bierrenbach AL; Barbosa da Silva J; Tauil PL; de Fátima Duarte E
    J Epidemiol Community Health; 2009 Mar; 63(3):233-8. PubMed ID: 19066188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with mortality and default among patients with tuberculosis attending a teaching hospital clinic in Accra, Ghana.
    Burton NT; Forson A; Lurie MN; Kudzawu S; Kwarteng E; Kwara A
    Trans R Soc Trop Med Hyg; 2011 Dec; 105(12):675-82. PubMed ID: 21920570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.